{"name":"Ivantis, Inc.","slug":"ivantis-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQSUxlRzdMcGxTcm5LbndHSGU5ZXlocE5TWkJCVFFRLWItam5kcmJWVG5HN3Y3Ul9ndVk0MXJybEVPQkszM1YtOWlNZWlidG02YnhBRzZzcFVWclR6c2w0UnB2UzJGYTRlR0pjRTQ4ZjY5U01zOEN2M2ZueGRWMXVuY2dDTVl5TFlWZ3dGQWJ2aTNjb1c5blktSDdTWVM?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Ocular Implants Market - openPR.com","headline":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Ocular Implants Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPOWZ4Wk0wMDVoT0Q4cmFuajM4V1ZQUUV6VEs5SXRPM3hiTklJU0hOaGdtSm5zSVFpZjRoS2syNW41OF9IdVJqcldINXVHZW5QRm1ESEdCZ2p3X3A0STdoUzhQY0VFN2hSQnRyLW45NXhYZURFb3JpcTV3clY3M0J6QVh5MXlnS3ZOZ0FQanRQMkVtLUJySGdULTloXzEweTF3VWVhTW1PZWhPTFFWVE02dlRlRDXSAXJBVV95cUxOZklSb1dVbGJLSElzNFZQU0xTajFNNVdtX3M4QWlPX2hpbVpwSU9WN05HNzB4NzNjcWtWY0Y0MlFaYUhRaFRuZG9FTnQ2Z2Y2TE9zbUVWdWp1VG84cGd0SXNxdWloalpJWDZlQk94dVNoQWc?oc=5","date":"2026-03-30","type":"patent","source":"Law360","summary":"Del. Judge Upholds $34M Verdict In Glaucoma Patent Feud - Law360","headline":"Del. Judge Upholds $34M Verdict In Glaucoma Patent Feud - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPOWFZNG5KbTFHX3FrN0pnUGJKcUd0SXNMaUFwYXQ2VDlnSVZrSFVqRnFaWlltRUlYamtQVlpRdEQ0UlBTV1I0SFh1Smo2WkMyQmI5bmNmazVIVjlDSjlYNkhKLVZyS0dRNEp2S3NnUWhUck1iNlpqTG8zS1pkYk5pR1Z2V2pudUlUZzZ5Vm5sclpBQi1GM0JhNnp0QWl0VllZLU5Jb1pfTXVjSkxXTUlRNkh2TQ?oc=5","date":"2023-03-01","type":"pipeline","source":"Pharmaceutical Executive","summary":"Investing in Glaucoma Innovation: Q+A with Alcon’s Ian Bell for World Glaucoma Week - Pharmaceutical Executive","headline":"Investing in Glaucoma Innovation: Q+A with Alcon’s Ian Bell for World Glaucoma Week","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPQ204Nm84dDI0bzl2aXJFOWVwVEZFTjNBWHJfS1B5M2QxbUY1ZE5yOW9YRUNfb1QwMnJmRG51YnRKdjNtM29uTjVMQk5rLXpTSmZuVXRrTzRGQXBGdEJPSjRqR1JtUEQya053bldTbEU2bXFDZG9fdDlhVTRWaWxGOWRvdUphUlpPUkE?oc=5","date":"2022-08-23","type":"pipeline","source":"BioWorld News","summary":"Alcon betters its view by acquiring Aerie - BioWorld News","headline":"Alcon betters its view by acquiring Aerie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQYUlrNlN5MnBnUWhoMWRZNzl3YUszRkNZbDdIUURybTVMU2pkZnBIemU3T3d6a1Z4Vm9tb1A0SktMMU96c1l5ODQwRUpOUUE0b3BuRWVOR2d3S3BiR0hrZS1kS0trc0VIdjhkT3NNaHRFazFVR003WVhxT2ExY2NrM2xNTW00aHNuam5iTVFNUS1hYVkzSld6SG9mRlA0dlZQNGcxSQ?oc=5","date":"2022-08-23","type":"deal","source":"Fierce Biotech","summary":"Alcon swoops on Aerie, striking $770M buyout to expand eye drug pipeline - Fierce Biotech","headline":"Alcon swoops on Aerie, striking $770M buyout to expand eye drug pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQd3ZwWkVLWDlKb1hxSlRwckFEaWFjWUpiQ0JiaXk2MXNNc05CVFRLeG81OG5WYXAzWjVGa3ExOUVMNVVyRDQwc3BKc0QwZkVWODJpWWZ4Nmwtak5BLUZBcnJQTDlPSmVNMkxzWl9QQVVSNlgxQURzWDREV2NHUjJ6WkFkY2ZHN0dDZm1zaUxWbm1qVlRuSzBtNjhpajVKWEVLdGU3UjhZenJkbzlUbGpwLTcwUQ?oc=5","date":"2021-09-15","type":"patent","source":"PR Newswire","summary":"Ivantis Announces Settlement of Glaukos Patent Litigation - PR Newswire","headline":"Ivantis Announces Settlement of Glaukos Patent Litigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQRjdJbTdleW0yaUFXalFGSmlNVXgxY0drNWtnT1lNVmFOMEx3RkdCbU8zeGhWb2NOTmdLSTFTVVJQMkZHd1NJT1lsWTAzUWFScXJYem52MGg3SHFuY0ZBVHlZZFRGX0FwUGszbHl2MU5xRUVTMXlxaTZiRjh0ZERZeU0tWnh5TXRqMndmamdaSlNGRU1HdlpndnlUclBEd3lxbnZjWEFqWmY0eTRUMTZCcTdOZDFxX0FqRng0NA?oc=5","date":"2020-12-16","type":"pipeline","source":"PR Newswire","summary":"Ivantis Recognized For Innovation, Excellence And Company Culture - PR Newswire","headline":"Ivantis Recognized For Innovation, Excellence And Company Culture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNR1FiMlpVQUlsQ0hhaV9UVkdJS3ZlNGtUM1ZCWGNlZVVqUWdfM2QtQ3RJREpoUHhpUmNCTWtLNXZJMUpLTXpnTXlKc2RqcGZLVW9tVW02RWl1ZXRuV3dKT0xXNGtWR2FhTHpUQ3VsbTJOMWN6UlQ2Y3lsaHF3d1ZfenJwbjB5R2pkdktNVC1UVFVfVHQ4V0gtWWI0MEcwMFJ5MV9rMXdhRUpSdXVzYy01dTZKMFVQMXAwNTJLSko5M2VFVm5tQjBTTUtMOVRHZ1NwSlhCUkJ4b2FHMHVLTTI2My1rSWZxVW1HRmxsUHE0d2JlUThQXzNEQmN4QQ?oc=5","date":"2020-08-13","type":"pipeline","source":"PR Newswire","summary":"Clearlake Capital-Backed Ivanti Announces Strategic Investment From TA Associates To Accelerate Company's Growth - PR Newswire","headline":"Clearlake Capital-Backed Ivanti Announces Strategic Investment From TA Associates To Accelerate Company's Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPQUFMTlM0cTlCR2dYcEh2X2Y4cjh6Rkp0OGtvV2JqNHFHRnFpbDRrcW9VRjFjQmxsTjU2cm1mVjQ4cmJYM1VQM0dCc1pvTFdEUF9taFRXdm1CWXp4ZWFFMkZnd09WX2dKaFJWR3ppRC1qNlVvdGE0UXhIRndISmQzel9SZVlKbGJQc2NRN3NCZW51ZXB5alpHOGo4eFNWem8xZVFuNUZuYkQxZUxtaGZaaDZUOENWTi1qVmFfRy1HTm1JZHF3TlBTWmpFQTYwZjNxcGM5LVd2Tm9iUmlDWGdVZW92SHR3QXFqQXNGcFpn?oc=5","date":"2019-03-14","type":"trial","source":"PR Newswire","summary":"Ivantis Announces 24-Month Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial - PR Newswire","headline":"Ivantis Announces 24-Month Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPRjNrUzR6eWt1eERfYi1PMFBjalNsV24zSnhUcUU0OHZnNzd2S0hZakQ5Ymd2WUVSVGszVUk4MWszaTJGN0o1cC1LbnJFd3kxNEcyc1czd2dkVFhWZlFaeEoxM0hBaXRUOGJ6RmZVNGxxaU9SR3owdWNoUnFXb0J2OHRYSVBqTnFld3NCaEJSbFdkS1Bsdk5sbGlSTGN6N1FoVzI0N2RhSUdsUU50VTFlYW9mNGpBRWNRWmUzM0ZITnVfVzNTbXBBajluNW9Pdk01QmFIclNLWVI5V3Q5TTlnQW90T2FMZk02Q1ZnaGpRcXFLNEJlcnNsT094VFBiMUFuXzIyZTFn?oc=5","date":"2018-08-13","type":"regulatory","source":"PR Newswire","summary":"Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS) - PR Newswire","headline":"Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIG","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2016-01-12","type":"pipeline","source":"Newswise","summary":"Glaucoma Research Foundation to Host Fifth Annual Glaucoma 360 New Horizons Forum | Newswise - Newswise","headline":"Glaucoma Research Foundation to Host Fifth Annual Glaucoma 360 New Horizons Forum | Newswise","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}